Brigatinib (AP26113)
Brigatinib is a highly potent and selective ALK (anaplastic lymphoma kinase) inhibitor. Potentially useful for the treatment of non-small cell lung cancer (NSCLC).
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog